What Hyalual does

Hyalual (legally Institute Hyalual GmbH, headquartered in Rotkreuz, Switzerland) is a privately held pharmaceutical manufacturer that develops and commercialises injectable aesthetic medicine products. The company was established in 2008, building on the legacy of YURIA-PHARM (founded 1990), and operates through nine wholly-owned subsidiaries across Ukraine, Italy, Poland, the United Kingdom, China, South Africa, Kazakhstan, Uzbekistan and Azerbaijan, alongside a distributor network covering more than 20 additional countries. Its product portfolio centres on the proprietary "Redermalization" procedure, delivered via the Xela Rederm line (non-cross-linked hyaluronic acid combined with succinic acid in 1.1%, 1.8% and 2.2% concentrations), the Alexa cross-linked hyaluronic acid dermal filler line for contouring and volumisation, and the Perfoskin Complex for fractional rejuvenation. Manufacturing runs from proprietary facilities in Italy and Ukraine with partner plants in Switzerland, Spain and the USA, all operating under ISO 13485, ISO 9001, GMP and EU MDR compliance.

The company generates revenue primarily through one-time sales of medical devices and cosmetic products to licensed medical professionals, supplemented by training and education services. Distribution is restricted exclusively to verified practitioners — dermatologists, aesthetic medicine doctors, nurses and aestheticians — accessed through a gated professional portal, regional subsidiaries, and authorised distributors in more than 20 countries. Hyalual supports this channel with a substantial training infrastructure (54 medical trainers, approximately 400 master classes annually, certified Applied Research Centres in the UK and Ukraine) and a contract-manufacturing platform at cm.hyalual.com that monetises spare production capacity via OEM services. The customer base comprises 35,000+ dermatologists and cosmetologists serving an installed base of 500,000+ end-treatment consumers. Pricing is not publicly disclosed and is handled country-by-country through local representatives and partners.

Strategic positioning is anchored in the "Science & Results" principle: clinically-supported, patented-combination injectables sold through a professional-only channel, with reach amplified by a training-led go-to-market model. The company participates regularly in major international congresses (AMWC, IMCAS, MWC, 5CC, Cosmoprof) and more than 60 local conventions annually, and publishes research in journals including Prime. Leadership is founder-led under CEO Dr. Nataliia Derkach, and the company has no disclosed external funding, M&A activity, or public-market listing in the available data.

Name

Hyalual

Legal name

Institute Hyalual GmbH

Website

https://hyalual.com

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

251–500 employees

Short description

Hyalual is a Swiss-headquartered pharmaceutical company that develops and manufactures injectable aesthetic medicine products — notably its proprietary Redermalization line combining hyaluronic acid and succinic acid — and sells them exclusively through verified medical professionals across more than 30 countries via nine subsidiaries and regional distributors.

Ownership category

akta.pro rank

Product category

Aesthetic medicine injectables

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Toilet Preparation Manufacturing (325620)

SIC

Surgical & Medical Instruments & Apparatus (3841), Perfumes, Cosmetics & Other Toilet Preparations (2844)

akta.pro primary industry

Cosmetic Dermatology (Aesthetic Injectables) (HLAKACAE)

akta.pro secondary industry

Dermocosmetics & Medical-Grade Skincare (CRABAAAF)

Keywords

• Aesthetic medicine injectables
• Dermal filler manufacturing
• Hyaluronic acid products
• Redermalization treatments
• Medical device distribution

Headquarters

HQ city

Rotkreuz

HQ country

Switzerland

HQ region

Europe

Offices5 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Marketing or Sales, Technology or R&D, Infrastructure, Others

Revenue model

1. Medical Devices and Cosmetic Products Sales: Hyalual generates revenue through the manufacture and sale of injectable aesthetic medicine products including redermalization preparations (Xela Rederm), dermal fillers (Alexa), and skincare products. Products are sold exclusively to licensed medical professionals through authorized distributors.
2. Training and Education Services: The company provides online education platforms, training courses, master classes, and professional forums for medical trainers and key opinion leaders in aesthetic medicine.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Hyalual develops, manufactures, and distributes injectable aesthetic medicine products, including the Xela Rederm line (hyaluronic acid combined with succinic acid in varying concentrations), Alexa dermal fillers, and Perfoskin Complex for fractional rejuvenation. These injectable medical devices are sold exclusively to licensed medical professionals (dermatologists, cosmetologists, aesthetic doctors and nurses) through a global subsidiary and distributor network for use in skin quality improvement, anti-aging, and redermalization procedures.

Product overview

Hyalual is a global developer and manufacturer of aesthetic medicine solutions founded in 2008. The product portfolio centers on injectable aesthetic treatments, primarily the Redermalization procedure using Xela Rederm (hyaluronic acid + succinic acid injectables), Alexa Fillers (dermal fillers), and Perfoskin Complex for combined protocols. The company also offers an online education platform with webinars and master classes, and provides contract manufacturing services. Products are distributed through certified medical professionals in over 20 countries, supported by 54 medical trainers and 400 annual master classes worldwide.

Differentiator

Problem solved

Functional benefit

Brands

• Xela Rederm: Injectable product line for redermalization procedures combining hyaluronic acid and succinic acid
• Alexa Fillers
• Perfoskin Complex
• Redermalization

Products and services

• Xela Rederm Injectable aesthetic medicine product combining non-cross-linked hyaluronic acid and succinic acid (sodium succinate) for skin quality improvement and redermalization procedures, offered in 1.1%, 1.8%, and 2.2% concentrations for different treatment protocols. Sold exclusively to licensed medical professionals.
• Alexa Fillers Cross-linked hyaluronic acid dermal fillers for contour plastic, facial volumization, and augmentation procedures including lip enhancement and periocular treatment. Sold to licensed medical professionals.
• Perfoskin Complex Complex used in fractional rejuvenation procedures combining microneedling technology with bioactive compounds for skin remodeling and anti-aging treatments, designed for use without rehabilitation period. Sold to licensed medical professionals.
• Redermalization procedure Proprietary injection methodology combining hyaluronic acid and succinic acid for dermal reprogramming, normalization of skin plasticity and energy metabolism, and age-related change correction. Marketed and trained to licensed medical professionals through Hyalual's trainer network.
• Contract Manufacturing OEM/contract manufacturing services for aesthetic medicine products provided to third parties under Hyalual's proprietary production capabilities via a dedicated cm.hyalual.com platform.
• Online Education Platform Web-based professional training platform providing webinars, master classes, recorded educational content, and certification programs for medical professionals and key opinion leaders in aesthetic medicine worldwide.

Quantifiable outcome

• 500,000 satisfied customers worldwide
• +1 more outcomes

Named customers2 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Two partnerships are on record, tiered core.

• Professional Distributors NetworkcoreChannel Partner/ Reseller/ DistributorPartnership with professional distributors in more than 20 countries for distribution of Hyalual aesthetic medicine products to licensed medical professionals.
• Regional Distribution PartnerscoreChannel Partner/ Reseller/ DistributorMultiple regional distributors including: Gen-Albfarma (Albania), A-Estetique (Armenia), Avromed (Azerbaijan), MED&SKIN (Belgium, France), Commercial Hialuronico Chile (Chile), Beijing Academi Health (China), Pontus Pharma (Croatia), Beauty Labs (Cyprus), INFOKRASA (Czech Republic), and many others across Europe, Asia, Africa, and Americas.

Scale indicators10 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Galderma: Global aesthetics dermatology leader with the Restylane HA filler range and Sculptra biostimulator. Direct product overlap with Hyalual's Alexa and Xela Rederm franchises and direct customer overlap with dermatologists and aesthetic practitioners.
• AbbVie / Allergan Aesthetics: Owns the Juvederm HA filler family and Botox, the market-leading injectable aesthetics portfolio. Direct product substitution risk for Hyalual's Alexa filler line and overlap on the aesthetic practitioner customer segment.

Direct peers

• Merz Aesthetics: Aesthetics subsidiary of Merz Group selling Belotero HA fillers, Radiesse biostimulators, and Ultherapy. Direct head-to-head competitor in HA injectables targeting dermatology and aesthetic practices, served via medical-only distribution channels.
• Sinclair Pharma: Specialty aesthetics company with Ellanse biostimulator and MaiLi HA filler ranges, sold exclusively through medical channels in 60+ countries. Closely comparable in company size, channel model, and product mix (HA + biostimulator) to Hyalual.
• TEOXANE: Swiss-based developer of RHA (Resilient Hyaluronic Acid) dermal filler ranges and skincare line, distributed exclusively to medical professionals. Most comparable in geographic origin (Swiss HQ), product category (HA fillers), and medical-only channel strategy.
• IBSA Derma: Division of IBSA Group marketing Profhilo (hybrid HA complexes for skin bio-remodeling). Closest conceptual analogue to Hyalual's Redermalization procedure in targeting skin quality rather than volumization, with a similar medical-channel and KOL-training GTM.
• Croma-Pharma: Austrian-based manufacturer of Princess HA fillers and orthovisc viscosupplements distributed through medical channels across Europe and Asia. Comparable mid-size specialty player competing in the same HA injectable category as Hyalual.

Emerging players

• Prollenium Medical Technologies: Canadian manufacturer of HA dermal fillers (Revanesse line) with growing international distribution. Emerging competitor in the HA filler category, similar specialty positioning and medical-only channel approach.
• Hugel (Aesthetics division): Korean-based manufacturer with botulinum toxin (Botulax) and HA filler products distributed across Asia and emerging markets. Comparable company size and stage, with growing international reach overlapping Hyalual's distributor footprint in Asia.

Regional players

• Suneva Medical: US-focused aesthetics company commercializing Bellafill, Sil-K, and the Evolus (Jeuveau) botulinum toxin portfolio. Comparable product mix (injectables + skincare adjacencies) and exclusive reliance on physician distribution; primarily competing with Hyalual in US/partner-plant geographies.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/hyalualuk

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hyalual